Insights & Resources

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

Shale maturation and technological innovation impact IP valuations, influencing long-term asset value and productivity in the oil and gas industry.

Companies looking to transform their operations through AI will need to guard against risk from vendors without a SOC 2 report. Learn more here.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.

Maximize your digital transformation investment by tracking ROI with quantifiable metrics, alignment with strategic objectives and continuous improvement.

Dashboards are catalysts for decision-making and operational excellence when businesses incorporate user-centric design and include key insights and alerts.

PCI DSS sets the standard for payment card security in higher education detailing compliance levels, reporting requirements and strategies to protect data.

Discover how AI and machine learning are revolutionizing forensic accounting by enhancing transaction reviews, anomaly detection and risk assessments.

As the food and beverage industry has served up big changes in recent years, Weaver’s strategies may help food, beverage and hospitality businesses navigate the leading trends of 2024.

AI is revolutionizing industries, but misleading claims are rampant. Learn how the SEC combats AI washing and the importance of transparency for investment advisers.

Unravel life sciences industry complexities, and discover the differences between FDA special review designations like Fast Track, Priority Review and Breakthrough.